Literature DB >> 20570793

[Role of environmental factors in the etiology of hepatocellular carcinoma].

István Tornai1.   

Abstract

Chronic B and C virus hepatitis (HBV and HCV) are the most important risk factors in the development of hepatocellular carcinoma (HCC). About 40-50% of HCC is induced by these two chronic viral infections. Prevalence of HCC is slowly increasing in the United States and in Western-Europe, whereas alcohol consumption is gradually decreasing in the majority of these countries. However, the most important environmental risk factor for HCC is still the heavy long-term alcohol use. The risk of cirrhosis and HCC increases linearly, wherever ethanol intake is greater than 60 g/day for men and women. Aflatoxin, which contaminates grains, mostly in China and Africa, is a well-known mycotoxin. Since geographical distribution of aflatoxin as well as HBV overlaps with each other, they have a synergistic effect on inducing HCC. Cigarette smoking has also hepatocarcinogenic effect, which is significantly enhanced by the concomitant alcohol use or chronic viral hepatitis. Obesity, non-alcoholic fatty liver and steatohepatitis as well as diabetes mellitus together also form a significant risk for HCC, due to the gradually increasing number of patients. Insulin resistance and oxidative stress are the major pathogenetic mechanisms leading to hepatic cell injury in these patients. Oral contraceptive drugs may also play a role in the development of HCC. The long-term exposure to organic solvents is also a risk factor for HCC. Dietary antioxidants, selenium, statins and coffee drinking have protective effect against HCC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20570793     DOI: 10.1556/OH.2010.28913

Source DB:  PubMed          Journal:  Orv Hetil        ISSN: 0030-6002            Impact factor:   0.540


  3 in total

1.  New insights on non-B non-C hepatocellular carcinoma in mid Delta Region, Egypt.

Authors:  Abdel Raouf Abou El Azm; Mohamed Yousef; Nagwa Mansour; Aymen Awad; Samia El Dardiry; Ibrahim Abdel Aziz
Journal:  J Gastrointest Cancer       Date:  2014-09

2.  Arsenic trioxide and sorafenib combination therapy for human hepatocellular carcinoma functions via up-regulation of TNF-related apoptosis-inducing ligand.

Authors:  Lingyan Wang; Zhihui Min; Xiangdong Wang; Mushuang Hu; Dongli Song; Zhenggang Ren; Yunfeng Cheng; Yanhong Wang
Journal:  Oncol Lett       Date:  2018-06-18       Impact factor: 2.967

3.  Serum anti-P53 antibodies and alpha-fetoprotein in patients with non-B non-C hepatocellular carcinoma.

Authors:  Abdel Raouf Abou El Azm; Mohamed Yousef; Raafat Salah; Wael Mayah; Salwa Tawfeek; Hussien Ghorabah; Nagwa Mansour
Journal:  Springerplus       Date:  2013-02-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.